Comparison of Effectiveness of Vaginal Versus Intramuscular Progesterone for the Prevention of Preterm Delivery

Authors

  • Kaniz Fatima Department of Obstetrics and Gynaecology, KRL Hospital, Islamabad Pakistan
  • Saima Qamar Department of Obstetrics and Gynaecology, KRL Hospital, Islamabad Pakistan
  • Nazneen Akhter Department of Obstetrics and Gynaecology, KRL Hospital, Islamabad Pakistan
  • Ayesha Basharat Department of Obstetrics and Gynaecology, KRL Hospital, Islamabad Pakistan
  • Beenish Riaz Department of Obstetrics and Gynaecology, KRL Hospital, Islamabad Pakistan
  • Naila Javaid Department of Obstetrics and Gynaecology, KRL Hospital, Islamabad Pakistan

DOI:

https://doi.org/10.51253/pafmj.v76iSUPPL-3.13488

Keywords:

Intramuscular progesterone, Preterm delivery, Vaginal progesterone

Abstract

Objective: To compare the effectiveness of vaginal progesterone versus intramuscular progesterone for the prevention of preterm delivery.  

Study Design: Quasi Experimental study

Place and Duration of Study: Department of Obstetrics and Gynaecology, KRL Hospital, Islamabad, from 31st Aug 2022 to 2nd March,2023.

Methodology: A total of 170 women between 24 to 36+6 weeks of gestation with singleton pregnancy and at risk of preterm birth, with short cervical length (10th percentile for the gestational age) were recruited after taking written informed consent. Patients were divided into two groups: In Group-A, patients were administered 200 mg of vaginal progesterone pessary once daily and in Group-B, 250 mg of intramuscular progesterone were injected weekly. The treatment was continued until 34 completed weeks of gestation in case of continuation of pregnancy.Therapy was discontinued if premature rupture of membranes or miscarriage occurred and the fetus was delivered before 37 weeks.

Results: Our study shows that in Group A mean age was 30 years with SD ± 7.11 whereas in Group B mean age was 29 years with SD ± 6.95. Group A (Vaginal Progesterone) was effective in 75(88%) patients whereas Group B (Intramuscular Progesterone) was effective in 60(71%) patients. Statistical analysis revealed a P-value of 0.0044, indicating a significant difference in effectiveness between the two treatment modalities.

Conclusion: Vaginal progesterone is more effective than intramuscular progesterone for the prevention of preterm labour. 

Downloads

Download data is not yet available.

References

1. Liang X, Lyu Y, Li J, Li Y, Chi C. Global, regional, and national burden of preterm birth, 1990–2021: a systematic analysis from the global burden of disease study 2021. EClinicalMedicine. 2024; 76: 102840.

https://doi.org/10.1016/j.eclinm.2024.102840

2. Lincetto O, Banerjee A. World prematurity day: improving survival and quality of life for millions of babies born preterm around the world. Am J Physiol Lung Cell Mol Physiol. 2020; 319(5): L871–4.

https://doi.org/10.1152/ajplung.00479.2020

3. Conde-Agudelo A, Romero R, Rehal A, Brizot ML, Serra V, Da Fonseca E, et al. Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in twin gestations: a systematic review and meta-analysis. Am J Obstet Gynecol. 2023; 229(6): 599–616.e3.

https://doi.org/10.1016/j.ajog.2023.05.010

4. Ward A, Greenberg V, Valcarcel B, Boelig RC, Al-Kouatly HB, Berghella V. Corrigendum to intramuscular progesterone in women with twins and a prior singleton spontaneous preterm birth. Am J Obstet Gynecol MFM. 2024; 6(10): 101479.

https://doi.org/10.1016/j.ajogmf.2024.101479

5. Ofman G, Pradarelli B, Caballero MT, Bianchi A, Grimaldi LA, Sancilio A, et al. Respiratory failure and death in vulnerable premature children with lower respiratory tract illness. J Infect Dis. 2020; 222(7): 1129–1137.

https://doi.org/10.1093/infdis/jiaa046

6. van Winden T, Roos C, Mol BW, Pajkrt E, Oudijk MA. A historical narrative review through the field of tocolysis in threatened preterm birth. Eur J Obstet Gynecol Reprod Biol X. 2024; 22: 100313. https://doi.org/10.1016/j.eurox.2024.100313

7. Nelson DB, Lafferty A, Venkatraman C, McDonald JG, Eckert KM, McIntire DD, et al. Association of vaginal progesterone treatment with prevention of recurrent preterm birth. JAMA Netw Open. 2022; 5(10): e2237600.

https://doi.org/10.1001/jamanetworkopen.2022.37600

8. Di Renzo GC, Tosto V, Tsibizova V, Fonseca E. Prevention of preterm birth with progesterone. J Clin Med. 2021; 10(19): 1–11.

9. Norman JE. Progesterone and preterm birth. Int J Gynecol Obstet. 2020;150(1):24–30.

10. Wajid R, Zafar M, Waheed F. Effectiveness of vaginal versus intramuscular progesterone for the prevention of preterm delivery. Ann King Edward Med Univ. 2016; 22(4). https://doi.org/10.21649/akemu.v22i4.1461

11. Pinto F, Fernandes E, Virella D, Abrantes A, Neto MT. Born preterm: a public health issue. Port J Public Health. 2019; 37(1): 38–49. https://doi.org/10.1159/000497249

12. Mfipa D, Hajison PL, Mpachika-Mfipa F. Predictors of low birthweight and comparisons of newborn birthweights among different groups of maternal factors at Rev. John Chilembwe Hospital in Phalombe district, Malawi: a retrospective record review. PLoS One. 2024; 19(8): 1–18.

https://doi.org/10.1371/journal.pone.0291585

13. Muzzamil M, Nisa M, Raza S. The survival rate of neonates in Pakistan: problems in health care access, quality and recommendations. Health Promot Perspect. 2022; 12(4): 355–357. https://doi.org/10.34172/hpp.2022.46

14. Dalili M, Barkhori-Mehni M, Robati FK. A comparison of neonatal outcomes after taking progesterone pills and progesterone intramuscular injections in preterm labor: an RCT. Int J Reprod Biomed. 2023; 21(7): 531–540.

https://doi.org/10.18502/ijrm.v21i7.13888

15. Hezelgrave NL, Suff N, Seed P, Robinson V, Carter J, Watson H, et al. Comparing cervical cerclage, pessary and vaginal progesterone for prevention of preterm birth in women with a short cervix (SuPPoRT): a multicenter randomized controlled trial. PLoS Med. 2024; 21(7): 1–15. https://doi.org/10.1371/journal.pmed.1004427

16. Harb M, Mohamed A, Adel AE. Vaginal versus intramuscular progesterone in the prevention of recurrent preterm labour. Al-Azhar Int Med J. 2021

https://doi.org/10.21608/aimj.2021.65704.1426

17. Ibrahem MA, Mostafa A, Elfath A, Basheer MJ. Role of vaginal progesterone in prevention of preterm labour in patients with history of spontaneous preterm delivery. Zagazig Univ Med J. 2024; 30(1). https://doi.org/10.21608/zumj.2023.240935.2935

18. Conde-Agudelo A, Romero R, Da Fonseca E, O'Brien JM, Cetingoz E, Nicolaides KH, et al. Vaginal progesterone for the prevention of preterm birth in asymptomatic women with a singleton pregnancy and a short cervix: a systematic review and meta-analysis of individual patient data. J Perinat Med. 2022; 50(9): 1113–1131.

https://doi.org/10.1515/jpm-2022-0462

Downloads

Published

30-04-2026

Issue

Section

Original Articles

Categories

How to Cite

1.
Fatima K, Qamar S, Nazneen Akhter, Ayesha Basharat, Beenish Riaz, Naila Javaid. Comparison of Effectiveness of Vaginal Versus Intramuscular Progesterone for the Prevention of Preterm Delivery. Pak Armed Forces Med J [Internet]. 2026 Apr. 30 [cited 2026 May 22];76(SUPPL-3):S598-S601. Available from: https://pafmj.org/PAFMJ/article/view/13488